Artigo
Fatty acids composition and in vivo biochemical effects of Aleurites moluccana seed (Candlenut) in obese wistar rats
Carregando...
Notas
Data
Orientadores
Editores
Coorientadores
Membros de banca
Título da Revista
ISSN da Revista
Título de Volume
Editor
Springer Nature
Faculdade, Instituto ou Escola
Departamento
Programa de Pós-Graduação
Agência de fomento
Tipo de impacto
Áreas Temáticas da Extenção
Objetivos de Desenvolvimento Sustentável
Dados abertos
Resumo
Abstract
Background: Candlenut (CN) has been used indiscriminately for weight loss. In vivo efects of CN in diferent doses
are scarce.
Objective: To evaluate the efects of CN ingestion in obese rats.
Design: Thirty animals (obese and non-obese) received one of three diferent types of treatments: placebo, CN
ingestion in a popular therapeutic regimen (8 days with oral administration of 0.2 mg/kg followed by 20 days with
doses of 0.4 mg/kg), and ingestion of a doubled popular dose—called 2CN. Treatment was maintained for 28 days.
Results: The fatty acid profle of CN indicated mainly linolelaidic and palmitoleic acids. Rats receiving CN and 2CN
showed reduced plasmatic levels of glucose and lipoproteins (p<0.05). A dose-dependent carcass fat reduction was
observed (p<0.05). Blood levels of aspartate aminotransferase (AST) and gamma-glutamyl transferase (GGT) reduced
with CN and increased with 2CN doses (p<0.05). Alanine aminotransferase (ALT) and the atherogenic index remained
similar among all treatments (p>0.05). Hepatic vacuolation decreased with CN, but the 2CN dose produced mononu‑
clear leucocyte infltrate.
Conclusions: Although CN presented benefcial efects on the metabolism of rats, it also caused increased risk of
liver damage.
Descrição
Área de concentração
Agência de desenvolvimento
Palavra chave
Marca
Objetivo
Procedência
Impacto da pesquisa
Resumen
Palavras-chave
ISBN
DOI
Citação
ROSA, M. C. de B. et al. Fatty acids composition and in vivo biochemical effects of Aleurites moluccana seed (Candlenut) in obese wistar rats. Diabetology & Metabolic Syndrome, [S.I.], v. 14, 2022. DOI: https://doi.org/10.1186/s13098-022-00847-4.
Link externo
Avaliação
Revisão
Suplementado Por
Referenciado Por
Licença Creative Commons
Exceto quando indicado de outra forma, a licença deste item é descrita como acesso aberto

